Simond AM, Bui T, Zuo D, Sanguin-Gendreau V, et al. Physiological expression of PI3K H1047R mutation reveals its anti-metastatic potential in ErbB2-driven breast cancer. Oncogene 2022 May 10. pii: 10.1038/s41388-022-02323.
PMID: 35538223